Literature DB >> 24227852

Characterization of the noncoding regions of the 1918 influenza A H1N1 virus.

Ruixue Wang1, Jeffery K Taubenberger.   

Abstract

The terminal noncoding region (NCR) sequences of the eight gene segments of the influenza A/Brevig Mission/1/1918 (H1N1) virus were determined by rapid amplification of cDNA ends (RACE). Chimeric viruses encoding the open reading frames of the 1918 virus but flanked by either the wild-type 1918 NCR sequences or the NCR sequences of two other H1N1 virus strains, A/WSN/1933 and A/New York/312/2001, were produced. No growth differences between the NCR variant 1918 influenza viruses were noted.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24227852      PMCID: PMC3911614          DOI: 10.1128/JVI.03098-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Autopsy series of 68 cases dying before and during the 1918 influenza pandemic peak.

Authors:  Zong-Mei Sheng; Daniel S Chertow; Xavier Ambroggio; Sherman McCall; Ronald M Przygodzki; Robert E Cunningham; Olga A Maximova; John C Kash; David M Morens; Jeffery K Taubenberger
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

2.  The influenza virus resource at the National Center for Biotechnology Information.

Authors:  Yiming Bao; Pavel Bolotov; Dmitry Dernovoy; Boris Kiryutin; Leonid Zaslavsky; Tatiana Tatusova; Jim Ostell; David Lipman
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

Review 3.  Genome packaging in influenza A virus.

Authors:  Edward C Hutchinson; Johann C von Kirchbach; Julia R Gog; Paul Digard
Journal:  J Gen Virol       Date:  2009-12-02       Impact factor: 3.891

4.  Characterization of the 1918 influenza virus polymerase genes.

Authors:  Jeffery K Taubenberger; Ann H Reid; Raina M Lourens; Ruixue Wang; Guozhong Jin; Thomas G Fanning
Journal:  Nature       Date:  2005-10-06       Impact factor: 49.962

Review 5.  Insights on influenza pathogenesis from the grave.

Authors:  Jeffery K Taubenberger; John C Kash
Journal:  Virus Res       Date:  2011-09-10       Impact factor: 3.303

6.  Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene.

Authors:  A H Reid; T G Fanning; J V Hultin; J K Taubenberger
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

7.  Mutational analyses of packaging signals in influenza virus PA, PB1, and PB2 genomic RNA segments.

Authors:  Yuhong Liang; Taoying Huang; Hinh Ly; Tristram G Parslow; Yuying Liang
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

8.  Role of sialic acid binding specificity of the 1918 influenza virus hemagglutinin protein in virulence and pathogenesis for mice.

Authors:  Li Qi; John C Kash; Vivien G Dugan; Ruixue Wang; Guozhong Jin; Robert E Cunningham; Jeffery K Taubenberger
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

9.  Discovery and characterization of the 1918 pandemic influenza virus in historical context.

Authors:  Jeffery K Taubenberger; Johan V Hultin; David M Morens
Journal:  Antivir Ther       Date:  2007

Review 10.  Pathogenesis of the 1918 pandemic influenza virus.

Authors:  Tokiko Watanabe; Yoshihiro Kawaoka
Journal:  PLoS Pathog       Date:  2011-01-27       Impact factor: 6.823

View more
  3 in total

1.  Identification of a Type-Specific Promoter Element That Differentiates between Influenza A and B Viruses.

Authors:  Shuman Gao; Wenyu Zhang; Congyu Lu; Mengmeng Cao; Shan Cen; Yousong Peng; Tao Deng
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

2.  New insights into the nonconserved noncoding region of the subtype-determinant hemagglutinin and neuraminidase segments of influenza A viruses.

Authors:  Lili Zhao; Yousong Peng; Kai Zhou; Mengmeng Cao; Jingfeng Wang; Xue Wang; Taijiao Jiang; Tao Deng
Journal:  J Virol       Date:  2014-07-23       Impact factor: 5.103

3.  Mapping inhibitory sites on the RNA polymerase of the 1918 pandemic influenza virus using nanobodies.

Authors:  Jeremy R Keown; Zihan Zhu; Loïc Carrique; Haitian Fan; Alexander P Walker; Itziar Serna Martin; Els Pardon; Jan Steyaert; Ervin Fodor; Jonathan M Grimes
Journal:  Nat Commun       Date:  2022-01-11       Impact factor: 17.694

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.